A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
Clinical trial NCT05733013 · RECRUITING
Trial details
- NCT number
- NCT05733013
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-07
- Primary completion
- 2028-02-07
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.